Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly and Co

Recent news which mentions Eli Lilly and Co

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Tags Amgen Inc Health & Science Pharmaceuticals
From CNBC.com News
Treasury yields dip slightly as Fed trajectory remains in focus
Tags Markets Economic events Prices
From CNBC.com News
Treasury yields down slightly as recent trend continues
Tags Delta Air Lines Inc United Airlines Holdings Inc Breaking News: Markets
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Technology US STEEL DRN Business
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
Tags Weight management Structure Therapeutics Inc Amgen Inc
From CNBC.com News
Patients regain weight after stopping Eli Lilly's Zepbound, study says
Tags Health & Science Pharmaceuticals US: News
From CNBC.com News
Treasury yields inch higher ahead of Fed meeting
Tags Bank of America Corp World Markets Moderna Inc
From CNBC.com News
Biden administration asserts power to seize drug patents in move to slash high prices
Tags Politics Government and politics Policy
From CNBC.com News
Cramer examines Tuesday's market 'mistakes,' points out underappreciated stocks
Tags Stock Picks Markets stocks
From CNBC.com News
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
Tags Business News Biotechnology Biotech and Pharmaceuticals
From CNBC.com News
Cramer says the growing popularity of weight loss drugs brings new investing opportunities
Tags Business News Investment Strategy Investment strategy
From CNBC.com News
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
Tags Companies Health care industry Abbott Laboratories
From CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Tags Weight management Health & Science Pharmaceuticals
From CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
Tags Biotech and Pharmaceuticals Biotechnology Novo Nordisk A/S
From CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
Tags Biotechnology Biotech and Pharmaceuticals Science
From CNBC.com News
This key element of ESG investing could drive real change at companies and boost returns
Tags Microsoft Corp Evercore Partners Inc H/B/ Fuller Company
From CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
Tags Business News Business Investment Strategy
From CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
Tags Business News Biotech and Pharmaceuticals Biotechnology
From CNBC.com News
Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
Tags stocks Markets Target Corp
From CNBC.com News
FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
Tags Biotechnology Biotech and Pharmaceuticals Breaking News: Business
From CNBC.com News
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
Tags Pharmaceuticals Health & Science Pfizer Inc
From CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
Tags Earnings Eli Lilly and Co US: News
From CNBC.com News
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
Tags Pharmaceuticals Health & Science Earnings
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Kraft Heinz Co Paramount Global Business News
From CNBC.com News
Cramer's week ahead: Federal Reserve meeting, Apple and Eli Lilly earnings
Tags Yum! Brands Inc Investment strategy Business
From CNBC.com News
Treasury yields continue retreat after 10-year slips back below 5%
Tags U/S/ Markets Johnson & Johnson US: News
From CNBC.com News
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
Tags Investing Health & Science Breaking News: Investing
From CNBC.com News
Treasury yields rise again as 10-year hovers near 5%
Tags Bitcoin Moderna Inc World Markets
From CNBC.com News
Sanofi to offer insulin product for $35 to all Americans through GoodRx
Tags Walgreens Boots Alliance Inc CVS Health Corp US: News
From CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
Tags Biotech and Pharmaceuticals Biotechnology Breaking News: Investing
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.